Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: lung carcinoma
Age: Between 18 - 100 Years
Gender: Male or Female
In order to be eligible to take part in this trial, patients must meet the following criteria:
- Clinical stage IB (>= 4 cm), II or IIIA non-squamous non-small cell lung cancer (NSCLC)
- Eastern Cooperative Oncology Group (ECOG) performance status 0-1
For a full list of participation criteria, please visit ClinicalTrials.gov.
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required